HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer

BACKGROUND: HER2 overexpression has been investigated as a potential biomarker and therapeutic target in biliary tract cancer (BTC), but a prognostic role of such alteration has not been demonstrated yet. MATERIALS AND METHODS: We retrospectively evaluated HER2 protein expression by immunohistochemi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Vivaldi, Caterina, Fornaro, Lorenzo, Ugolini, Clara, Niccoli, Cristina, Musettini, Gianna, Pecora, Irene, Cacciato Insilla, Andrea, Salani, Francesca, Pasquini, Giulia, Catanese, Silvia, Lencioni, Monica, Masi, Gianluca, Campani, Daniela, Fontantini, Gabriella, Falcone, Alfredo, Vasile, Enrico
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Hepatobiliary
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543291/
https://ncbi.nlm.nih.gov/pubmed/32353192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0922
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares